Evidence map›Paper›PMID 29301838›Full record

ArticleCirculation research2018

Cardiac Cell Cycle Activation as a Strategy to Improve iPSC-Derived Cardiomyocyte Therapy.

June-Wha Rhee, Joseph C Wu

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

June-Wha RheeFrom the Stanford Cardiovascular Institute (J.-W.R., J.C.W.), Division of Cardiovascular Medicine, Department of Medicine (J.-W.R., J.C.W.), and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA.
Joseph C WuFrom the Stanford Cardiovascular Institute (J.-W.R., J.C.W.), Division of Cardiovascular Medicine, Department of Medicine (J.-W.R., J.C.W.), and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA. joewu@stanford.edu.

Funding

Human Induced Pluripotent Stem Cells for Cardiovascular Disease ModelingR01HL113006 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2012 to 2025
$6.8M
Genome Editing of Human iPSCs to Study Inherited Hypertrophic CardiomyopathyR01HL126527 · NHLBI · STANFORD UNIVERSITY · PI QI, LEI STANLEY, WU, JOSEPH C. · 2015 to 2022
$5.4M
Molecular Imaging of Cardiac Pluripotent Stem CellsR01HL133272 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2016 to 2020
$2.4M
The use of human induced pluripotent stem cell-derived cardiomyocytes to describe the role of α-Tropomyosin mutations in hypertrophic cardiomyopathyF32HL134221 · NHLBI · STANFORD UNIVERSITY · PI RHEE, JUNE-WHA · 2016 to 2019
$169k
NHLBI NIH HHS F32 HL134221NHLBI NIH HHS R01 HL113006NHLBI NIH HHS R01 HL126527NHLBI NIH HHS R01 HL133272
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell CycleCyclin D2Heart VentriclesHumansInduced Pluripotent Stem CellsMyocytes, CardiacCCND2 protein, humanCyclin D2cell cyclecell transplantationEditorialsheart failuremyocyte, cardiacpluripotent stem cell

Identifiers

PMID29301838
PMCPMC5773069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.